EFM
ALNY icon

E Fund Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

E Fund Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.83M Sell
6,073
-1
-0% -$302 0.04% 166
2026
Q1 		$2.01M Buy
+6,074
New +$2.07M 0.06% 151
2025
Q2 		$1.17M Sell
3,594
-9,114
-72% -$2.52M 0.06% 147
2025
Q1 		$3.43M Buy
12,708
+413
+3% +$106K 0.16% 87
2024
Q4 		$2.89M Sell
12,295
-342
-3% -$89.9K 0.15% 86
2024
Q3 		$3.48M Buy
12,637
+7,711
+157% +$2.01M 0.18% 63
2024
Q2 		$1.2M Buy
4,926
+2,112
+75% +$333K 0.07% 112
2024
Q1 		$421K Sell
2,814
-526
-16% -$87.7K 0.03% 198
2023
Q4 		$639K Buy
3,340
+1,069
+47% +$182K 0.04% 119
2023
Q3 		$402K Sell
2,271
-70
-3% -$13.4K 0.03% 168
2023
Q2 		$445K Buy
2,341
+226
+11% +$44.8K 0.04% 134
2023
Q1 		$424K Buy
2,115
+287
+16% +$60.3K 0.03% 147
2022
Q4 		$434K Sell
1,828
-306
-14% -$65.3K 0.04% 162
2022
Q3 		$427K Sell
2,134
-1,181
-36% -$225K 0.04% 164
2022
Q2 		$483K Buy
3,315
+1,583
+91% +$225K 0.04% 145
2022
Q1 		$283K Buy
+1,732
New +$264K 0.01% 218

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

E Fund Management's ALNY Position: Q2 2026 in Review

E Fund Management reduced its Alnylam Pharmaceuticals (ALNY) stake by 0.02% in Q2 2026, selling an estimated $302 and leaving 6,073 shares worth $1.83M. The position accounts for 0.04% of the portfolio, ranked #166.

E Fund Management first reported a position in ALNY in Q1 2022 and has held it in 16 quarters since. The position peaked at $3.48M in Q3 2024. 785 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • E Fund Management held 6,073 shares of Alnylam Pharmaceuticals worth $1.83M as of Q2 2026.
  • E Fund Management sold 1 Alnylam Pharmaceuticals share in Q2 2026, an estimated $302.
  • Alnylam Pharmaceuticals made up 0.04% of E Fund Management's portfolio in Q2 2026, its #166 holding.
  • E Fund Management first reported a position in Alnylam Pharmaceuticals in Q1 2022 and has held it in 16 quarters since.
  • E Fund Management's Alnylam Pharmaceuticals position peaked at $3.48M in Q3 2024.
  • 785 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.